Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | RMC-9805 |
| Trade Name | |
| Synonyms | RMC 9805|RMC9805 |
| Drug Descriptions |
RMC-9805 inhibits KRAS G12D, which potentially results in reduced downstream signaling and proliferation, induction of apoptosis, and decreased tumor growth (Cancer Res 2023;83(7_Suppl):Abstract nr 526). |
| DrugClasses | KRAS G12D Inhibitor 25 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Carboplatin + Daraxonrasib + Pemetrexed Disodium + RMC-9805 | Carboplatin Daraxonrasib Pemetrexed Disodium RMC-9805 | 0 | 1 |
| Cisplatin + Daraxonrasib + Pemetrexed Disodium + RMC-9805 | Cisplatin Daraxonrasib Pemetrexed Disodium RMC-9805 | 0 | 1 |
| Daraxonrasib + Pembrolizumab + RMC-9805 | Daraxonrasib Pembrolizumab RMC-9805 | 0 | 1 |
| RMC-9805 | RMC-9805 | 0 | 2 |
| RMC-9805 + TNG462 | RMC-9805 TNG462 | 0 | 1 |